[ad_1]
Research Highlights:
- Obesity is linked to 30-53% of new diabetes cases in the U.S. yearly.
- Obesity has remained a major driver of diabetes for the last two decades.
- Obesity-related diabetes varies by gender and race/ethnicity, and the greatest impact is among non-Hispanic white females.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, Feb. 10, 2021
(NewMediaWire) – February 10, 2021 – DALLAS – Reducing the prevalence of obesity may prevent up to half of new Type 2 diabetes cases in the United States, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association. Obesity is a major contributor to diabetes, and the new study suggests more tailored efforts are needed to reduce the incidence of obesity-related diabetes.
Type 2 diabetes is the most common form of diabetes, affecting more than 31 million Americans, according to the U.S. Centers for Disease Control and Prevention[1]. The risk factors for Type 2 diabetes include being overweight or having obesity; being over the age of 45; having an immediate family member diagnosed with Type 2 diabetes; being physically active less than 3 times per week; or a history of gestational diabetes (diabetes during pregnancy). Type 2 diabetes is more common among people who are Black, Hispanic or Latino, American Indian, Alaska Native, Pacific Islander or Asian American.
The number of deaths due to Type 2 diabetes in people younger than 65 is increasing along with serious complications of the condition, including amputations and hospitalizations. In addition, Type 2 diabetes impacts heart disease and stroke risk: adults with Type 2 diabetes are twice as likely to have a heart attack or stroke than people without diabetes.
Type 2 diabetes can be prevented or delayed with healthy lifestyle changes, such as losing weight, eating healthy food and being physically active. According to the National Diabetes Prevention Program, behavior changes have been shown to help people with prediabetes lose 5% – 7% of their body weight and reduce their risk of developing type 2 diabetes by 58% (71% for people older than age 60). Researchers examined the prevalence and excess risk of Type 2 diabetes associated with obesity.
“Our study highlights the meaningful impact that reducing obesity could have on Type 2 diabetes prevention in the United States. Decreasing obesity needs to be a priority. Public health efforts that support healthy lifestyles, such as increasing access to nutritious foods, promoting physical activity and developing community programs to prevent obesity, could substantially reduce new cases of Type 2 diabetes,” says the study’s first author Natalie A. Cameron, M.D., a resident physician of internal medicine at the McGaw Medical Center of Northwestern University in Chicago.
Researchers used information from the Multi-Ethnic Study of Atherosclerosis (MESA) and four pooled cycles (2001-2016) of the National Health and Nutrition Examination Survey (NHANES). MESA is an ongoing, longitudinal study of 45 to 84-year-olds who did not have cardiovascular disease upon recruitment. MESA data included in this study was collected during five visits from 2000 to 2017 at six centers across the U.S. NHANES is a cross-sectional study of the American population that takes place every other year using patient questionnaires and examination data.
For this analysis, authors limited data to participants ages 45 to 79-years old. They included only those who were non-Hispanic white, non-Hispanic Black or Mexican American and who did not have either Type 1 or Type 2 diabetes at the beginning of the study. Researchers calculated both the prevalence of obesity and the excess risk of Type 2 diabetes associated with obesity.
The study’s findings include:
- Among NHANES participants, the overall prevalence of obesity increased from 34% to 41% and was consistently higher among adults with Type 2 diabetes.
- Among MESA participants
- about 1 in 10 (11.6%) developed Type 2 diabetes after nine years.
- People with obesity were nearly three times as likely to develop Type 2 diabetes compared to those without obesity (20% vs. 7.3%, respectively).
- In both the MESA and NHANES groups:
- Obesity was linked to the development of Type 2 diabetes in 30 – 53% of cases.
- a greater proportion of participants with obesity had an annual family income of less than $50,000, and they were more likely to be non-Hispanic Black or Mexican American.
- Obesity prevalence was the lowest among non-Hispanic white females, however, this group experienced the highest obesity-related Type 2 diabetes.
“Our study confirms there is a higher prevalence of obesity among non-Hispanic Black adults and Mexican-American adults compared to non-Hispanic white adults. We suspect these differences may point to important social determinants of health that contribute to new cases of Type 2 diabetes in addition to obesity,” says Cameron.
“Additionally, the obesity epidemic has collided with the COVID-19 pandemic,” says Sadiya S. Khan, M.D., M.Sc., the study’s senior author and an assistant professor of medicine and preventive medicine at Northwestern University’s Feinberg School of Medicine. “The greater severity of COVID-19 infection in individuals with obesity is concerning because of the growing burden of adverse health consequences they could experience in the coming years; therefore, further efforts are needed to help more adults adopt healthier lifestyles and hopefully reduce the prevalence of obesity.”
This analysis included only middle-aged to older adults without cardiovascular disease who were non-Hispanic white, non-Hispanic Black or Mexican-American, so results may not be generalizable to the entire U.S. population. Future research is required to assess the burden of obesity on new cases of Type 2 diabetes in other age groups and racial and ethnic groups.
Co-authors are Lucia C. Petito, Ph.D.; Megan McCabe, M.S.; Norrina B. Allen, Ph.D., M.P.H.; Matthew J. O’Brien, M.D.; and Mercedes R. Carnethon, Ph.D., FAHA.
This research was supported by grants from the National Institutes of Health, the National Heart, Lung, and Blood Institute and the National Center for Advancing Translation Sciences at the National Institutes of Health, and the American Heart Association.
Additional Resources:
Statements and conclusions of studies published in the American Heart Association’s scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers are available here, and the Association’s overall financial information is available here.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
###
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Maggie Francis: 214-706-1382; maggie.francis@heart.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org
[ad_2]